172 related articles for article (PubMed ID: 34853322)
21. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.
Osawa Y; Oboki K; Imamura J; Kojika E; Hayashi Y; Hishima T; Saibara T; Shibasaki F; Kohara M; Kimura K
EBioMedicine; 2015 Nov; 2(11):1751-8. PubMed ID: 26870800
[TBL] [Abstract][Full Text] [Related]
22. Boosting the hypoxic response in myeloid cells accelerates resolution of fibrosis and regeneration of the liver in mice.
Kantari-Mimoun C; Krzywinska E; Castells M; Milien C; Klose R; Meinecke AK; Lemberger U; Mathivet T; Gojkovic M; Schrödter K; Österreicher C; Fandrey J; Rundqvist H; Stockmann C
Oncotarget; 2017 Feb; 8(9):15085-15100. PubMed ID: 28118605
[TBL] [Abstract][Full Text] [Related]
23. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
24. Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.
Wang J; Lu Z; Xu Z; Tian P; Miao H; Pan S; Song R; Sun X; Zhao B; Wang D; Ma Y; Song X; Zhang S; Liu L; Jiang H
Sci Rep; 2017 Jan; 7():41038. PubMed ID: 28112200
[TBL] [Abstract][Full Text] [Related]
25. C-C motif chemokine receptor 2 inhibition reduces liver fibrosis by restoring the immune cell landscape.
Guo Y; Zhao C; Dai W; Wang B; Lai E; Xiao Y; Tang C; Huang Z; Gao J
Int J Biol Sci; 2023; 19(8):2572-2587. PubMed ID: 37215993
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
Patsenker E; Popov Y; Stickel F; Schneider V; Ledermann M; Sägesser H; Niedobitek G; Goodman SL; Schuppan D
Hepatology; 2009 Nov; 50(5):1501-11. PubMed ID: 19725105
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Benefits of Spleen Tyrosine Kinase Inhibitor Administration on Binge Drinking-Induced Alcoholic Liver Injury, Steatosis, and Inflammation in Mice.
Bukong TN; Iracheta-Vellve A; Gyongyosi B; Ambade A; Catalano D; Kodys K; Szabo G
Alcohol Clin Exp Res; 2016 Jul; 40(7):1524-30. PubMed ID: 27177528
[TBL] [Abstract][Full Text] [Related]
28. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
29. Osteoarthritis-associated basic calcium phosphate crystals activate membrane proximal kinases in human innate immune cells.
Corr EM; Cunningham CC; Helbert L; McCarthy GM; Dunne A
Arthritis Res Ther; 2017 Feb; 19(1):23. PubMed ID: 28173838
[TBL] [Abstract][Full Text] [Related]
30. A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney.
Ma FY; Blease K; Nikolic-Paterson DJ
Life Sci; 2016 Feb; 146():192-200. PubMed ID: 26779657
[TBL] [Abstract][Full Text] [Related]
31. HMGB1 mediates Aspergillus fumigatus-induced inflammatory response in alveolar macrophages of COPD mice via activating MyD88/NF-κB and syk/PI3K signalings.
Zhang P; Xin X; Fang L; Jiang H; Xu X; Su X; Shi Y
Int Immunopharmacol; 2017 Dec; 53():125-132. PubMed ID: 29078091
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
[TBL] [Abstract][Full Text] [Related]
33. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
34. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.
Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
[TBL] [Abstract][Full Text] [Related]
35. Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of
Dagher Z; Xu S; Negoro PE; Khan NS; Feldman MB; Reedy JL; Tam JM; Sykes DB; Mansour MK
Front Immunol; 2018; 9():1058. PubMed ID: 29868018
[TBL] [Abstract][Full Text] [Related]
36. CD11b + CD43 hi Ly6C lo splenocyte-derived macrophages exacerbate liver fibrosis via spleen-liver axis.
Zhang S; Wan D; Zhu M; Wang G; Zhang X; Huang N; Zhang J; Zhang C; Shang Q; Zhang C; Liu X; Liang F; Zhang C; Kong G; Geng J; Yao L; Lu S; Chen Y; Li Z
Hepatology; 2023 May; 77(5):1612-1629. PubMed ID: 36098707
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol crystals activate Syk and PI3 kinase in human macrophages and dendritic cells.
Corr EM; Cunningham CC; Dunne A
Atherosclerosis; 2016 Aug; 251():197-205. PubMed ID: 27356299
[TBL] [Abstract][Full Text] [Related]
38. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
39. Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis.
Tacke F
Expert Opin Investig Drugs; 2018 Mar; 27(3):301-311. PubMed ID: 29448843
[TBL] [Abstract][Full Text] [Related]
40. Chronic intermittent hypoxia accelerates liver fibrosis in rats with combined hypoxia and nonalcoholic steatohepatitis via angiogenesis rather than endoplasmic reticulum stress.
Wu W; Li W; Wei J; Wang C; Yao Y; Zhu W; He W; Zhou W; Liu J
Acta Biochim Biophys Sin (Shanghai); 2019 Feb; 51(2):159-167. PubMed ID: 30668625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
